Efficacy of losartan, valsartan, and telmisartan in patients with mild to moderate hypertension: A double-blind, placebo-controlled, crossover study using ambulatory blood pressure monitoring

Current Therapeutic Research - Clinical and Experimental

Volumn 63, Issue 1, 2002, Pages 1-14

  Fogari, Roberto ^a   Mugellini, Amedeo ^a   Zoppi, Annalisa ^a   Derosa, Giuseppe ^a   Rinaldi, Andrea ^a   Fogari, Elena ^a   Vanasia, Alessandro ^a   Preti, Paola ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Ambulatory blood pressure monitoring; Hypertension; Losartan; Telmisartan; Valsartan

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; LOSARTAN; PLACEBO; TELMISARTAN; VALSARTAN;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; MALE; OUTPATIENT; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0036157640     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(02)80002-9     Document Type: Article

References (26)

1. A new class of antihypertensive therapy: Angiotensin II receptor antagonists
2. Angiotensin II receptor antagonists
3. Angiotensin II receptor blockers: Review of the binding characteristics
4. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension
5. Newly emerging pharmacologic differences in angiotensin II receptor blockers
6. Pharmacology and clinical efficacy of angiotensin receptor blockers
7. A double-blind cross-over study of the antihypertensive efficacy of angiotensin II-receptor antagonists and their activation of the renin-angiotensin system
8. Angiotensin II antagonists for hypertension: Are there differences in efficacy?
9. Angiotensin II antagonists for hypertension: There are differences in efficacy
10. Ambulatory blood pressure monitoring use in hypertension research and clinical practice
11. A review of national guidelines on the clinical use of ambulatory blood pressure monitoring
12. Relationship of 24-hour blood pressure variability to severity of target organ damage in hypertension
13. Prognostic value of 24-hour blood pressure variability
14. Losartan potassium: A review of its pharmacology, clinical efficacy and tolerability in the management of hypertension
15. Valsartan. A review of its pharmacology and therapeutic use in essential hypertension
16. Telmisartan
17. Calculation of trough:peak ratio of antihypertensive treatment from ambulatory blood pressure: Methodological aspects
18. Trough:peak ratio: The rationale behind the United States Food and Drug Administration recommendations
19. Suggested guidelines for determining the trough-to-peak ratio of antihypertensive drugs
20. Beyond trough peak ratio: A new index of the smoothness of the antihypertensive effect of a drug
21. The smoothness index: A new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension
22. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives
23. Validation of the SpaceLabs 90202 and 90207 devices for ambulatory blood pressure monitoring by comparison with intra-arterial resting and ambulatory measurements
24. Comparative efficacy of losartan and valsartan in mild to moderate essential hypertension: Results of 24-hour ambulatory blood pressure monitoring
25. Angiotensin II receptor blockade in TGR(mREN2)27: Effects of renin-angiotensin-system gene expression and cardiovascular functions